Indicators

Markets:

News

Latest News about CTLT

Recent news which mentions CTLT

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

This is the window of time when value can outperform growth in the stock market

January 18, 2022

FDA Concerns At Catalent Site Spurred Novo Nordisk's Wegovy Supply Woes: Report

January 14, 2022

A Look Into Catalent's Price Over Earnings

December 30, 2021

Benzinga's Top Ratings Upgrades, Downgrades For December 16, 2021

December 16, 2021

Expert Ratings For Catalent

November 03, 2021

Catalent, inc (CTLT) Q1 2022 Earnings Call Transcript

November 02, 2021

The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US

November 02, 2021

The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline

October 31, 2021

7 Healthcare Stocks to Add to Your Portfolio

October 06, 2021

Chair And CEO Of Catalent Trades $22M In Company Stock

October 06, 2021

The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test

September 10, 2021

The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization

September 09, 2021

Where Catalent Stands With Analysts

September 08, 2021

The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod

September 08, 2021

The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself

September 03, 2021

The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab

September 02, 2021

10 Biggest Price Target Changes For Tuesday

August 31, 2021

Catalent, inc (CTLT) Q4 2021 Earnings Call Transcript

August 30, 2021

Mid-Afternoon Market Update: Affirm Shares Jump Following News Of Amazon Partnership; Adtran Shares Drop

August 30, 2021

Mid-Day Market Update: Nasdaq Jumps Over 100 Points; Astra Space Shares Plunge

August 30, 2021

Mid-Morning Market Update: Markets Mixed; Catalent To Acquire Bettera

August 30, 2021

Catalent Makes Strategic Move For Consumer Health Business With Bettera Deal

August 30, 2021

A Peek Into The Markets: US Stock Futures Edge Higher After S&P 500, Nasdaq Hit Record Highs

August 30, 2021

5 Stocks To Watch For August 30, 2021

August 30, 2021

Earnings Scheduled For August 30, 2021

August 30, 2021

The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration

August 27, 2021

The Daily Biotech Pulse: Early Approval For Ascendis' Pediatric Growth Hormone Deficiency Treatment, Redhill Biopharma Spikes On Positive COVID-19 Drug Data, RenovoRx IPO

August 26, 2021

A Look Into Catalent's Price Over Earnings

August 25, 2021

Catalent's Debt Overview

August 25, 2021

EMA Approves Additional Sites To Boost Output Capacity For mRNA-Based COVID-19 Vaccines

August 25, 2021

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.